11/27
02:47 pm
fbrx
Forte Biosciences (NASDAQ:FBRX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings .
Low
Report
Forte Biosciences (NASDAQ:FBRX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings .
11/27
06:18 am
fbrx
Forte Biosciences (NASDAQ:FBRX) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Low
Report
Forte Biosciences (NASDAQ:FBRX) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
11/25
07:19 am
fbrx
Forte Biosciences (NASDAQ:FBRX) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
Low
Report
Forte Biosciences (NASDAQ:FBRX) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
11/24
04:01 pm
fbrx
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
Medium
Report
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
11/21
01:59 pm
fbrx
Forte Biosciences (NASDAQ:FBRX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings .
Medium
Report
Forte Biosciences (NASDAQ:FBRX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings .
11/17
08:06 am
fbrx
Forte Biosciences (NASDAQ:FBRX) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $61.00 price target on the stock.
Low
Report
Forte Biosciences (NASDAQ:FBRX) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $61.00 price target on the stock.
11/14
09:00 am
fbrx
Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update
Medium
Report
Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update
11/3
04:01 pm
fbrx
Forte Biosciences, Inc. to Present at Upcoming Healthcare Conferences
Medium
Report
Forte Biosciences, Inc. to Present at Upcoming Healthcare Conferences
11/14
04:10 pm
fbrx
Form SCHEDULE 13G/A Forte Biosciences, Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P
Low
Report
Form SCHEDULE 13G/A Forte Biosciences, Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P
11/14
04:00 pm
fbrx
Form SCHEDULE 13G/A Forte Biosciences, Inc. Filed by: ALGER ASSOCIATES INC
Low
Report
Form SCHEDULE 13G/A Forte Biosciences, Inc. Filed by: ALGER ASSOCIATES INC
11/14
09:06 am
fbrx
Form 10-Q Forte Biosciences, Inc. For: Sep 30
Medium
Report
Form 10-Q Forte Biosciences, Inc. For: Sep 30
11/14
09:05 am
fbrx
Form 8-K Forte Biosciences, Inc. For: Nov 14
Medium
Report
Form 8-K Forte Biosciences, Inc. For: Nov 14
10/7
11:08 am
fbrx
Form SCHEDULE 13G/A Forte Biosciences, Inc. Filed by: FEDERATED HERMES, INC.
Low
Report
Form SCHEDULE 13G/A Forte Biosciences, Inc. Filed by: FEDERATED HERMES, INC.
10/2
04:10 pm
fbrx
Form 4 Forte Biosciences, Inc. For: Oct 01 Filed by: Riley Antony A
High
Report
Form 4 Forte Biosciences, Inc. For: Oct 01 Filed by: Riley Antony A
10/2
04:09 pm
fbrx
Form 4 Forte Biosciences, Inc. For: Oct 01 Filed by: Wagner Paul A.
High
Report
Form 4 Forte Biosciences, Inc. For: Oct 01 Filed by: Wagner Paul A.
9/30
04:06 pm
fbrx
Form S-8 Forte Biosciences, Inc.
Medium
Report
Form S-8 Forte Biosciences, Inc.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register